TransKora Logistics — Investment Proposition & Funding Request
TransKora Logistics is seeking total funding of ZAR 120 million, structured as follows:
Section 12 · Business Plan
Investment Proposition & Funding Request
TransKora Logistics is seeking total funding of ZAR 120 million, structured as follows:
Approximately USD 6.5 million, with dividends anticipated from Year 3 and a clear path to profitability by Year 2.
12.1 Funding Requirement
TransKora Logistics is seeking total funding of ZAR 120 million, structured as follows:
| Funding Source | Amount (ZAR m) | % of Total | Terms |
| Equity Capital | 72.0 | 60% | Ordinary shares |
| Project Finance Debt | 48.0 | 40% | 7-year amortising |
| Total | 120.0 | 100% |
12.2 Use of Funds
| Category | Amount (ZAR m) | % of Total |
| Fleet Acquisition & Customisation | 70.0 | 58% |
| Depot & Maintenance Infrastructure | 25.0 | 21% |
| IT & Fleet Management Systems | 10.0 | 8% |
| Working Capital | 10.0 | 8% |
| Contingency Reserve | 5.0 | 5% |
| Total | 120.0 | 100% |
12.3 Investor Returns
TransKora offers an attractive risk-adjusted return profile for equity investors:
-
Target IRR: 18–20% (base case), with upside potential of 24–26% under the bull case scenario.
-
Dividend Policy: Dividends anticipated from Year 3, with a target payout ratio of 30–40% of net profit after tax.
-
Exit Options: Trade sale to a strategic acquirer (regional logistics operator or PE fund), secondary sale to institutional investors, or IPO on the JSE AltX within 5–7 years.
12.4 IRR Sensitivity Analysis
Figure 10: IRR Sensitivity Analysis – Bear / Base / Bull Scenarios
The sensitivity analysis considers three scenarios:
-
Bear Case (IRR 13%): Revenue 20% below base case, fleet utilisation at 55%, higher-than-expected fuel and labour costs.
-
Base Case (IRR 19%): Revenue and cost assumptions as per the financial projections in Section 8.
-
Bull Case (IRR 26%): Revenue 15% above base case, fleet utilisation at 90%, faster route expansion, and favourable exchange rate movements.
This document contains proprietary and confidential information. Distribution without written consent is prohibited.